Project Number GC-2013118 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Accelerating Manufacture of Clinical Supplies for Initiation of Patient Enrollment in the HOPE4MCI Phase 3 Trial (AgeneBio, AGB101) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator ROSENZWEIG-LIPSON, SHARON Principal Investigator First Name SHARON Principal Investigator Last Name ROSENZWEIG-LIPSON Awardee Organization AgeneBio Inc Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $798,087 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
